Price Alert

ASLAN Pharmaceuticals Lim... (ASLN)

NASDAQ: ASLN · Real-Time Price · USD

0.60

-0.10 (-14.27%)

At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	18.4M	21.25M	40.82M	40.94M	57.5M	56.9M	57.75M	61.58M	85.82M	90.17M	100.5M	94.12M	100.82M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	11.2M	16.54M	1.59M	n/a	n/a	n/a	n/a
Long-Term Investments	235.57K	235.57K	n/a	n/a	-2.95K	8.59K	54.1K	132.25K	336.23K	494.73K	643.61K	818.56K	n/a
Other Long-Term Assets	n/a	1.72K	n/a	n/a	n/a	8.59M	n/a	n/a	n/a	n/a	2M	132.07K	70.05K
Receivables	n/a	171.44K	n/a	12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	528.84K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.18M	2.71M	3.47M	2.14M	2.61M	3.98M	3.23M	2.24M	2.96M	3.61M	1.42M	615.21K	397.13K
Total Current Assets	20.58M	24.13M	44.29M	55.08M	60.11M	60.88M	72.17M	80.36M	90.37M	93.78M	101.93M	94.74M	101.74M
Property-Plant & Equipment	176.39K	259.25K	340.39K	123.06K	208.07K	292.74K	376.87K	109.94K	168.33K	232.72K	284.16K	338.83K	404.5K
Goodwill & Intangibles	686.00	1.72K	2.75K	3.78K	4.81K	5.84K	6.87K	7.9K	8.93K	9.96K	10.99K	12.02K	n/a
Total Long-Term Assets	412.65K	496.53K	343.14K	126.84K	209.93K	307.16K	437.83K	250.08K	513.49K	737.41K	2.93M	1.29M	474.55K
Total Assets	20.99M	24.63M	44.64M	55.21M	60.32M	61.19M	72.61M	80.61M	90.88M	94.52M	104.85M	96.02M	102.22M
Account Payables	9.66M	7.92M	4.42M	6.3M	10.02M	12.78M	11.04M	9.44M	7.35M	3.12M	2.88M	2.05M	1.94M
Deferred Revenue	2.35M	n/a	2.33M	2.41M	n/a	n/a	n/a	n/a	n/a	2.82M	n/a	n/a	n/a
Short-Term Debt	7.32M	2.03M	13.79M	13.45M	10.75M	7.96M	282.74K	50.12K	124.76K	199.12K	346.31K	281.31K	161.6K
Other Current Liabilities	280.65K	3.17M	439.03K	2.19M	2.47M	2.42M	2.87M	2.03M	1.91M	223.35K	2.92M	2.79M	3.45M
Total Current Liabilities	19.6M	13.11M	20.98M	24.36M	23.24M	23.16M	14.19M	11.53M	9.39M	6.36M	6.14M	5.12M	5.56M
Long-Term Debt	19.35M	24.8M	24.54M	24.48M	27.19M	29.66M	36.35M	36.42M	36.42M	30.86M	30.81M	15.28M	15.38M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	272.24K	111.99K
Total Long-Term Liabilities	19.35M	24.8M	24.54M	24.48M	27.19M	29.66M	36.35M	36.42M	36.42M	30.86M	30.81M	15.55M	15.49M
Total Liabilities	38.95M	37.91M	45.52M	48.84M	50.43M	52.82M	50.55M	47.95M	45.8M	37.21M	36.95M	20.67M	21.05M
Total Debt	26.67M	26.83M	38.33M	37.93M	37.94M	37.62M	36.64M	36.47M	36.54M	31.06M	31.16M	15.56M	15.54M
Common Stock	65.19M	63.93M	63.85M	63.7M	63.62M	63.02M	63.02M	63.02M	63.02M	63.02M	63.02M	63.01M	63.01M
Retained Earnings	-330.99M	-321.07M	-309.09M	-299.38M	-297.5M	-278.39M	-263.91M	-252.98M	-239.94M	-227M	-216.43M	-207.83M	-202.4M
Comprehensive Income	56.62K	24.07M	-178.95K	-178.95K	-178.95K	-178.95K	-178.95K	-178.95K	-178.95K	-178.95K	8.16M	-178.95K	-178.95K
Shareholders Equity	-17.96M	-13.29M	-881.73K	6.37M	9.89M	8.37M	22.06M	32.67M	45.07M	57.3M	67.9M	75.35M	81.12M
Total Investments	235.57K	235.57K	n/a	n/a	-2.95K	8.59K	11.25M	16.68M	1.92M	494.73K	643.61K	818.56K	n/a